8489 Materi Kuliah FK Umi
8489 Materi Kuliah FK Umi
8489 Materi Kuliah FK Umi
230 = 1,073,741,824
= 1 billion cells
2-6 weeks
Signs and Symptoms of Cancer
Change in bowel habits or bladder functions
Sores that do not heal
Unusual bleeding or discharge
Lumps or thickening of breast or other parts of
the body
Indigestion or difficulty swallowing
Recent change in wart or mole
Persistent coughing or hoarseness
Types of Cancers
Carcinomas (cells
that cover internal and
external body surfaces) Leukemia
(Blood Cells)
Lung
Lymphomas
Breast (Lymph nodes &tissues)
Colon
Bladder
Prostate Sarcomas
(Men) Cells in supportive
tissues – bones &
muscles
What Causes Cancer?
Family History
Lifestyle
Environment
What Causes Cancer?
External Factors – chemicals, radiation,
viruses, and lifestyle
Internal Factors – hormones, immune
conditions, and inherited mutations
Theories
Cellular change/mutation theories
Carcinogens
Oncogenes/ protooncogenes
Factors Believed to Contribute to Global
Causes of Cancer
Figure 16.2
Cancer pathogenesis
Oncogenes
myc, ras, src, abl, bcl2
Tumor suppressor genes
p53, Rb, APC, MEN1, NF1
MicroRNA
Transcriptome control
The path to cancer
Clonal proliferation
Starts from a single cell
Expansion in steps
Pre-malignant states
Polyp, MDS, MGUS
Serial accumulation of mutations
Clonal evolution
Resistance
“Hallmarks of cancer”
Is it necessary?
Normal vs abnormal mutation rate
2 current views
Chromosomal instability
Gross translocations, loss and gain of
chromosome parts
Mutator phenotype
Repair genes
Xeroderma pigmentosum
MMR etc
Cytogenetic abnormalities
Translocations
Balanced
Reciprocal
Aneuploidy
Pseudodiploid
Hyperdiploid
Complex
Hayflick hypothesis
Limited number of doublings
Telomere maintenance
Telomerase
• Autocrine loops
• Over-expression of
receptor
• Receptor is always
‘on’
• Downstream
signals
Insensitivity to antigrowth signals
Evading apoptosis
External triggers
Intracellular triggers
Death receptors
Caspases
Sensors (8, 9)
Executioners (3)
Sustained angiogenesis
VEGF
FGF1/2
Thrombospondin
Thalidomide
Avastin
Tissue invasion and metastases
Tumor burden - Staging
Tumor
Size, capsule invasion
Nodes
Involved, how many?
Metastases
Present/absent
“Unknown primary”
Imaging
CT scan
PET/CT
SPECT/CT
MRI
Staging
Response
Prognostic scoring systems
Host vs Disease
Disease burden
Disease biology
Co-morbid conditions
Performance status
Good News!
2003 - 66%
Advances in cancer
research continue
The Fight Will Continue
Because…in 2007
Cancer is the second
leading cause of death in
Utah and the nation
186,550
The number of lives that could be
saved each year with no tobacco